Validation and Recalibration of Charlson and Elixhauser Comorbidity Indices Based on Data From a Japanese Insurance Claims Database

Overview of attention for article published in Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku, October 2019

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 15 Dimensions

Readers on

mendeley: 10 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 15 publications that cite this research output.

15

The most recent citing publications are shown below. View all 15 publications that cite this research output on Dimensions.

Prescription patterns and therapeutic effects of second-line drugs in Japanese patients with type 2 diabetes mellitus: Analysis of claims data for metformin and dipeptidyl peptidase-4 inhibitors as the first-line hypoglycemic agents

Article in Expert Opinion on Pharmacotherapy (April 2023)

Comparison of the effects on cardiovascular events between use of metformin and dipeptidyl peptidase-4 inhibitors as the first-line hypoglycaemic agents in Japanese patients with type 2 diabetes mellitus: a claims database analysis

Article in BMJ Open (March 2022)

Comparison of the incidence of bleeding between baloxavir marboxil and other anti‐influenza drugs among outpatients with influenza virus infection: A retrospective cohort study using an employment‐based health insurance claims database in Japan

Article in Pharmacoepidemiology and Drug Safety (December 2021)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.